The remit of the NREC-CTs is to review the submission of ethics applications related to Clinical Trials of Investigational Medicinal Products (CTIMP). This includes interventional studies and low-interventional studies involving medicinal products for human use.

The National Research Ethics Committee for Clinical Trials (NREC-CT) is recognised by the Department of Health under the S.I. No. 190/2004 - European Communities (Clinical Trials on Medicinal Products For Human Use) Regulations, 2004 and the S.I. No. 41/2022 European Union (Clinical Trials on Medicinal Products for Human Use) (National Research Ethics Committees) Regulations 2022. The NREC-CTs are authorised to carry out the ethics review of clinical trials of medicinal products.

The NREC-CT is fully compliant with the regulations as they relate to ethics committees, and endorses the conditions and principles of good clinical practice.

For further information related to the NREC-CT, please contact the National Office –

If you plan to submit a CTIMP application for ethics review, please visit Apply NREC-CT.

If you are interested in the underlying processes and management of the NREC-CT, please download our Operational Framework.

Details of all upcoming meetings, minutes and decisions are published here on our website. A full list of committee members can also be viewed.

Scroll to Top